Stockreport

Femasys Advances FemBloc Toward U.S. Approval with Initiation of Pivotal Trial Enrollment

Femasys Inc.  (FEMY) 
PDF -- Enrollment begins in the FDA-authorized FINALE pivotal trial evaluating FemBloc, a first-of-its-kind non-surgical permanent birth control, following positive clinical [Read more]